chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vaccine has attack a nerve in his face; I experienced soreness in my lower right jaw; It felt like someone had pulled out all my teeth simultaneously and poured acid into the cavities in my jaw; arm soreness; fatigue; slight fever; bad gum pain; achiness; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL NERVE DISORDER (vaccine has attack a nerve in his face), GINGIVAL PAIN (bad gum pain), PAIN (achiness), PAIN IN JAW (I experienced soreness in my lower right jaw) and FEELING ABNORMAL (It felt like someone had pulled out all my teeth simultaneously and poured acid into the cavities in my jaw) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0011321A and 029LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer (does not have any vocal chords due to previous bout with cancer.), Blood pressure high and Cardiac discomfort. Concomitant products included OMEPRAZOLE (OMEPRAZOL A) for Acid reflux (oesophageal), AMLODIPINE BESILATE (AMLODIPINE (ALS BESILAAT) SANDOZ) for Blood pressure high, DIPHENHYDRAMINE HCL for Runny nose.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced GINGIVAL PAIN (bad gum pain), PAIN (achiness), PAIN IN EXTREMITY (arm soreness), FATIGUE (fatigue) and PYREXIA (slight fever). On an unknown date, the patient experienced FACIAL NERVE DISORDER (vaccine has attack a nerve in his face), PAIN IN JAW (I experienced soreness in my lower right jaw) and FEELING ABNORMAL (It felt like someone had pulled out all my teeth simultaneously and poured acid into the cavities in my jaw). The patient was treated with GABAPENTIN at a dose of 1000 mg three times a day; AMOXICILLIN, CLAVULANATE POTASSIUM (AUGMENTINE SR) at an unspecified dose and frequency; CHLORHEXIDINE at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, FACIAL NERVE DISORDER (vaccine has attack a nerve in his face) outcome was unknown and GINGIVAL PAIN (bad gum pain), PAIN (achiness), PAIN IN JAW (I experienced soreness in my lower right jaw), FEELING ABNORMAL (It felt like someone had pulled out all my teeth simultaneously and poured acid into the cavities in my jaw), PAIN IN EXTREMITY (arm soreness), FATIGUE (fatigue) and PYREXIA (slight fever) had not resolved.            The patient had done EKG Physician has scheduled him a MRI of the Brain   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Follow up received contains significant information: event was updated. On 25-Jul-2021: Follow up received contains significant information: events ,lab details and concomitant medication provided, patient information was added
11/15/2022 Epistaxis, 11/16/2022 Bruising, 11/17/2022 platelets 9000. 11/17 Received immune globulin - sucrose free 10 % injection 10.9 g  11/18 platelets <2000 11/19 platelets 5000 11/21  platelets 35,000
Information regarding PREVNAR was received from a healthcare professional regarding an unspecified number of patients. The reporter stated that children cry the loudest and are most upset after the vaccine. It was also reported that this vaccine seems to be the most painful immunization for patients. The patient received a dose on an unspecified date. Relevant medical history was not provided. Indication for PREVNAR was immunization. Product was administered on an unspecified date. Dose regimen was 1 dose. Concomitant medications were not reported. The reporter stated that children cry the loudest (crying) and are most upset after the vaccine. It was also reported that this vaccine seems to be the most painful immunization for patients. Outcome was unknown. No additional information was available at the time of this report.
Patient was not ill at all prior to donation on 06/21/06, or at the time of the second rabies shot on 06/23/06. She left the center at 10:30 AM on 06/23/2006, at 03:00 PM on 6/23/2006, she began having horrible diarrhea and a mild headache. She had 15 episodes of diarrhea from 3 PM to 8 PM on 06/23/2006. Today no further diarrhea but her abdomen is sore. On 06/24/2006, there was no redness, heat, swelling or rash present on the right arm. Today BP is 120/66; Pulse 74; could not take temperature because patient had just drank a can of diet coke.
Large lump on anterior left lower leg, both sides of tibia. Size varies, but is still present. No prior trauma
Patient complained of pain in left arm (injection arm) and dizziness.  I monitored patient for anaphylaxis.  Patient showed no signs of anaphylaxis. I took her blood pressure and temperature.  BP was 75/35, heart rate = 68 and temperature 98.7.  I monitored patient for 30 minutes. After sipping on orange juice, she started to feel better.  Her mother was present.  I asked her mother who the child's doctor is and she stated that daughter has no doctor.  I recommended that her doctor be seen today to monitor.
About 10 days after covid booster, I started to feel intense itching/ bumps on stomach, then spread to most of upper torso and scalp. Days later, on arms, legs, feet, and hands. Itch intensely in evening.   Intense on scalp, and neck and itching hives come on all areas of my body.  Any pressure or clothing can create bumps.    I have no history of hives, have no new foods, detergent, environmental exposures or stress. I tried taking Benadryl and claritin.  With only mild success, but nothing helped. Went to urgent care and prescribed steroid cream.  Did not help Went to doctor and was diagnosed Chronic Urticaria. After 3 weeks no relief, intense hives still occurring any place on body. On 1/20/22 prescribed Prednisone (4mg Dospak 21s)  and Famotidine 20 mg taking Claritin during the day and Benadryl at night. The 5 day prednisone helped the hives.  But after the 5 day dose the hives returned. So a 10 day prednisone was prescribed.  Again it helped and the itching was less severe while still taking antihistamine. But now on 2/16/22 3 days after 2nd dose of prednisone.  The hives are back on neck and face and anywhere on body
Flu-like symptoms, including mild fever, congestion, headache, sneezing, and cough began a few days after son  tested positive for flu and strep throat.
Left deltoid large area of light redness and swelling size 4 x 5 in.
Patients eyes and half of her face swelled up along with a sore throat. She went to doctor and received prednisone (steroid).
Suspect case of vaccine-associated Bacillus cereus infection in a newborn.  The initial blood culture (see below) was positive for B. cereus.  The infant had a severe, febrile respiratory illness, diagnosed as RSV, which required hospitalization at Medical Center.  An older sibling had RSV pneumonia in December.  The infant has recovered fully.  01/24/2008 MR received from CDC for ER admit 1/5-7/2008 with primary DX:  RSV Bronchiolitis.  Additional DX: UTI. Infant presented to ER with 2 day hx of fever with decrease po intake, decreased UO and increased respirations. (+) cough. On PE pt appeared sleepy and dehydrated (10%). Mildly increased WOB with minimal subcostal retractions and tracheal tugging. Otherwise WNL. Pt admitted and tx with IVF, nebs and abx.
28JUN 1030AM recv vax cried w/inj & all the way home slept 1hr @ home then cried inconsolably for 3 hr w/high pitch cry; wouldn't eat; leg was purplish swollen & hard, knee to waist was also red; 230PM called PCP t101.2, inc APAP; fussy
Drug ineffective; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  An adult female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 02Dec2022 as dose 5 (booster), single (Lot number: GJ3275) for covid-19 immunisation; BNT162b2 (BNT162B2), on 15Jul2022 as dose 4 (booster), single (Lot number: FM7553) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "not recovered"; COVID-19 (medically significant), outcome "not recovered".  Therapeutic measures were taken as a result of drug ineffective, covid-19 (Paxlovid). No follow-up attempts are possible. No further information is expected.
Pt recv vax on 8/10/98; 4-5 hr later pt exp prickly red rash on arms &neck w/ itching.
Started with muscle soreness only on the right arm after 3-4 days of receiving the vaccinations. Patient waited for over a month for the soreness and pain to resolve by itself. Finally patient went to see her primary doctor on 9/5/19 and diagnosed with muscle inflammation.  Currently treating the inflammation with Voltaren 1% Gel and Medrol dosepak 4mg  prescribed to her by Dr.
I had pain at the injection site initially and it increased on day 2. Also on day 2, I saw a small rash after showering.  The muscle pain has de erased, but the injection site is very tender and the rash has spread down my arm about 2-3 inches.  Today, day 5, the rash is slightly itchy.   On day 2, I had chills, body aches, joint pain and a headache.  All symptoms were gone within 48 hours with the exception of the headache.  The headache lasted until day 5.
I felt itchy; Felt generally weak; Muscle ache; Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs; Sore thighs; Very tired/ extremely tired; Sore shoulders/Sore knees/Sore ankles; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore thighs), PRURITUS (I felt itchy), ASTHENIA (Felt generally weak), MYALGIA (Muscle ache) and FATIGUE (Very tired/ extremely tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: Codeine (Patient experienced itching after codeine.). Past adverse reactions to the above products included Itching with Codeine.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore thighs), FATIGUE (Very tired/ extremely tired), ARTHRALGIA (Sore shoulders/Sore knees/Sore ankles) and HEADACHE (Bad headache). On 26-Feb-2021, the patient experienced RASH (Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs). On an unknown date, the patient experienced PRURITUS (I felt itchy), ASTHENIA (Felt generally weak) and MYALGIA (Muscle ache). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 02-Mar-2021, RASH (Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore thighs), PRURITUS (I felt itchy), ASTHENIA (Felt generally weak), MYALGIA (Muscle ache), FATIGUE (Very tired/ extremely tired), ARTHRALGIA (Sore shoulders/Sore knees/Sore ankles) and HEADACHE (Bad headache) had resolved.            Patient was taking allergy shots since November 2020 twice a week and currently on a maintenance program.  Patient was broke out in rash twice about a day after injection. Rash was clear in a day or two and patient had no itching after rash broke out.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No new information received On 13-Jul-2021: Significant follow up appended
FELT WITHOUT STRENGTH; GAVE A TEMPERATURE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced felt without strength, and gave a temperature. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) UNKNOWN. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt without strength, and gave a temperature. This report was non-serious.
Tachycardic; stomach pain; severe headcahe; Dizziness; Low blood pressure; Muscle Aches; Chills; Muscle twitches at the injection site left arm; Sore arm; had a skin reaction right away; extreme fatigue; nausea; This spontaneous case was reported by a health care professional and describes the occurrence of SKIN REACTION (had a skin reaction right away), FATIGUE (extreme fatigue), NAUSEA (nausea), ABDOMINAL PAIN UPPER (stomach pain) and HEADACHE (severe headcahe) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 13-Jan-2021, the patient experienced SKIN REACTION (had a skin reaction right away), FATIGUE (extreme fatigue) and NAUSEA (nausea). On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 15-Jan-2021, the patient experienced INJECTION SITE REACTION (Muscle twitches at the injection site left arm). On 23-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), HEADACHE (severe headcahe), DIZZINESS (Dizziness), HYPOTENSION (Low blood pressure), MYALGIA (Muscle Aches) and CHILLS (Chills). On an unknown date, the patient experienced TACHYCARDIA (Tachycardic). On 13-Jan-2021, FATIGUE (extreme fatigue) and NAUSEA (nausea) had resolved. On 14-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 17-Jan-2021, INJECTION SITE REACTION (Muscle twitches at the injection site left arm) had resolved. On 23-Jan-2021, HEADACHE (severe headcahe), DIZZINESS (Dizziness), HYPOTENSION (Low blood pressure), MYALGIA (Muscle Aches) and CHILLS (Chills) had resolved. At the time of the report, SKIN REACTION (had a skin reaction right away), ABDOMINAL PAIN UPPER (stomach pain) and TACHYCARDIA (Tachycardic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jan-2021: No specific follow-up information recorded.
PATIENT SIGNED UP FOR A SECOND DOSE PFIZER VACCINE CLINIC AND WAS GIVEN THE SHOT EARLY.  HE SHOULD HAVE RECEIVED IT ON 6/8/21 AND INSTEAD RECEIVED IT ON 5/26/21. TO DATE NO ADVERSE EFFECT HAS BEEN REPORTED FROM THE PATIENT.  HAVE LEFT MESSAGES FOR HIM TO RETURN OUR PHONE CALL.
Hives, started on my arm on Monday, by Tuesday 04/27/21 hives increased to include my back also included chills and prickly sensation  I contacted my doctor (Unavailable) called MD  doctor on Wednesday 04/28/21 hives over 80% of my body-chills, itching, burning the  ordered Hydroxyzine 25mg  3x a day ; added Benadryl one tablet at night. on 4/30/2021 symptoms continued with no relief contacted my PCP she prescribed Famotidine 20mg 1 x a day. 05/03/2021 only slight improvement of rash but chills, itching  still exist.
Initial and follow-up information has been received from a pediatrician, a physician and a registered nurse for the pregnancy registry for GARDASIL concerning a 15 year old female patient who in September 2007 was vaccinated with her first dose of GARDASIL (Lot # 658094/0524U).  On 21-APR-2008, was vaccinated with her second dose of GARDASIL (Lot # 659657/1487U).  The patient became pregnant during her series of vaccination.  No adverse events were reported.  As of 22-AUG-2008 she was at 27 weeks gestation.  In follow-up information the registered nurse reported that the patient with a history of 0 pregnancies and 0 live births who was vaccinated on 18-SEP-2007 with the first dose of GARDASIL (Lot # 658094/0524U) became pregnant on 29-OCT-2008 (EDD 31-OCT-2008 also reported 01-NOV-2008) and on 29-OCT-2008 delivered a normal, healthy male baby weighing 7 pounds 11 ounces.  Follow-up information was received from a health professional who reported that the baby with no known drug allergies was seen at the doctor's office on 05-NOV-2008.  The baby weighted 6 lbs, 15 oz, the length was 20 inches, the head circumference was 31.5 inches and the temperature was 97.2F.  The baby was fed with formula received 2-3 times a day.  The baby did not present any problem with exception that was spitting up a little.  The diagnostic impression indicated a well newborn.  Additional information is not expected.
This spontaneous report from a physician concerns a newborn female: PDE2014DE119883. The baby weighed 3130 kilograms at birth. The baby's medical history was unknown. Other medical history included the baby's brother, aged 7, also suffered from club feet and retardation in development. The baby's mother received rabies vaccine (unspecified dose and route of administration) on 05-NOV-2014, influenza vaccine virosomal (unspecified dose) on 13-NOV-2013, typhus vaccine (unspecified dose and route of administration) on 18-NOV-2013 and rabies vaccine again on 26-NOV-2013, all for prophylactic vaccination. Non-company suspect drugs included: Tick-borne encephalitis vaccine on 05-NOV-2013, Meningococcal polysaccharide vaccine on 18-NOV-2013 and Japanese encephalitis vaccine on 26-NOV-2013, all for prophylactic vaccination. Concomitant medications were not reported. On 19-AUG-2014, the baby was delivered by cesarean section (41st week of gestation), due to weak CTG (cardiotocograph). The first assessment after delivery was not normal with weak muscle tonus and malformation of both feet (club feet). The baby was hospitalised. On the third day of life, the baby developed retardation of development and an infection with tachypnea.  Corrective treatment included Ampicillin and Tobramycin for seven days with infusions of flucose, electrolytes and aminio acids.  A decrease in oxygen saturation was observed until 30-AUG-2014. An x-ray revealed a very big sized heart and according to echo cardiac investigations, no evidence for vitium cordis or malfunction of the heart.  Orthopaedic investigations performed on 20-AUG-2014 confirmed club feet (both sites), questionable instable hip and length of achilles tendon was reduced.  The baby's club feet were treated by casts. On 01-SEP-2014, the baby was discharged from hospital in a good general condition. The outcome of the events was not reported. The reporter suspected that the baby's club feet were a genetically caused musculoskeletal syndrome and recommended an appointment with human genetics. The reporter did not suspect a causal relationship between vaccines, club feet and developmental retardation. This report was serious (hospitalization).
After the vaccine I waited a couple of minutes when I got up I felt dizzy. After this I had to get taken back to a room and waiting a couple more minutes and was able to go home.
I had my vaccine on May 18, 2021.  Prior to this date I was in good health.  I was in remission from  Ankylosing Spondylitis and Rheumatoid Arthritis for a 3 year period of time. I was off all meds related to this.  I was active and I am not over weight.  ( I have HBP and thyroid issues....All controlled).   After the vaccine, beginning around May 27, 2021 I started experiencing bi-lateral shoulder pain and my knees began to get stiff.  within the next week and after the symptoms got worse and started affecting all major joints.  I had a routine appointment with my Rheumatologist on June 21, but I called to been seen sooner because it was becoming difficult to stand, walk and the pain in my shoulders was severe and referred pain down my arms to my elbows.  I had an appointment on June 14, 2021 and had a blood test on the 18th.  The report came back with the highest numbers that I have ever had for inflammation.  There has been a lot of confusion at my doctors office but they are finally getting me approved to go back on biologics. I have been unable to do any of my normal activities and the pain throughout my body is a solid 10 on a 1-10 scale.  There isnt any relief currently and I am struggling.
Glioblastoma, IDH-wildtypeby IHC. Left temporal (with extension to left basal ganglia and insula) glioblastoma, IDH, wildtype by IHC
migraine, fever, sore throat, congestion, fatigue, body aches, nausea.
This is a spontaneous report from a contactable consumer. This consumer reported for a Physician. A male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown, expiry date: unknown) via intramuscular route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. It was unknown whether the patient receive any other vaccines within 4 weeks prior to the COVID vaccine and any other medications within 2 weeks of vaccination. It was unknown whether prior to vaccination, the patient diagnosed with COVID-19, and whether since the vaccination, the patient been tested for COVID-19. On an unspecified date, patient was tested positive for COVID. Doctor or other healthcare professional office/clinic visit took place due to the adverse events. The patient underwent lab test for SARS-CoV-2, with results as positive on an unspecified date. The outcome of events was unknown.   No follow-up attempts are needed. No further information is expected.
Information has been received for Pregnancy Registry for GARDASIL from a consumer's mother concerning her 18 year old daughter with no medical history who on 24-JAN-2007 was vaccinated with a first dose of GARDASIL.  Concomitant therapy included HEP B (unspecified) and Vitamins (Prenatal DHA).  The reporter mentioned that "her daughter received her first injection and found out that she was pregnant 2-3 weeks later."  No adverse event reported.  It was reported that she had a pregnancy test done.  On 27-SEP-2007, the patient delivered a normal, healthy female baby weighing 7 lbs and 6 oz, length 20, apgar score 8/9, head circumference not reported.  No congenital anomalies.  Complications during pregnancy or labor/delivery included Nuchal cord x 1 and cephalopelvis disproportion (1 CTC/S) failure to progress.  Diagnostic test during pregnancy included routine Quad screen, routine labs, culture and biophysical all within normal limits.  Upon internal review cephalopelvis disproportion and failure to progress were considered to be an other important medical event.  No further information is available.